Alignment Healthcare holder to sell 500K shares

A trust associated with Alignment Healthcare stock filed to resell 500,000 pre-IPO common shares under Rule 144.

Available on EDGAR 09/10/2026 - 04:38 PM EDT Accepted by SEC EDGAR 09/10/2026 - 04:37 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) is the issuer of common stock covered by this notice, which states that JEK TRUST U/A DTD 02/08/2021 plans to sell 500,000 shares of ALHC common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The shares were originally issued pre-IPO in exchange for partnership units.

Key Figures

Shares proposed to be sold under Rule 144: 500,000 shares Aggregate market value of proposed sale: $6,515,000.00 Shares sold on August 10, 2026: 298,000 shares +5 more

8 metrics

Shares proposed to be sold under Rule 144 500,000 shares Planned sale for JEK TRUST U/A DTD 02/08/2021 through Morgan Stanley Smith Barney LLC

Aggregate market value of proposed sale $6,515,000.00 Market value stated for 500,000 Alignment Healthcare common shares

Shares sold on August 10, 2026 298,000 shares Common stock sold for JEK TRUST under a 10b5-1 Sales Plan

Proceeds from August 10, 2026 sale $4,136,764.62 Sale of 298,000 Alignment Healthcare common shares

Shares sold on July 10, 2026 298,000 shares Common stock sold for JEK TRUST under a 10b5-1 Sales Plan

Proceeds from July 10, 2026 sale $5,919,352.80 Sale of 298,000 Alignment Healthcare common shares

Rule 144 filing date of notice September 10, 2026 Date of notice for the planned Rule 144 sale

Original issuance date of shares May 9, 2014 Shares issued pre-IPO in exchange for partnership units

Key Terms

Rule 144, 10b5-1 Sales Plan, Shares Issued Pre-IPO, Partnership Units

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales Plan regulatory

"10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021"

A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.

Shares Issued Pre-IPO financial

"Shares Issued Pre-IPO in exchange for Partnership Units"

Partnership Units financial

"Shares Issued Pre-IPO in exchange for Partnership Units"

Partnership units are ownership shares in a business organized as a partnership; owning a unit is like holding a slice of the company’s profit pie and a claim on its assets. For investors, these units matter because they determine how income, losses and cash distributions are allocated, affect voting or control rights, and often carry different tax and liquidity implications than corporate stock — think of them as a direct stake in the partnership’s performance and payouts.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Alignment Healthcare (ALHC)?

The filing discloses that JEK TRUST U/A DTD 02/08/2021 intends to sell 500,000 shares of Alignment Healthcare, Inc. common stock under Rule 144 through Morgan Stanley Smith Barney LLC, using shares that were originally issued pre-IPO in exchange for partnership units.

How many Alignment Healthcare (ALHC) shares are proposed to be sold under this Form 144?

The notice states that 500,000 shares of Alignment Healthcare, Inc. common stock are proposed to be sold for the account of JEK TRUST U/A DTD 02/08/2021 under Rule 144.

What prior Alignment Healthcare (ALHC) share sales are reported in the last three months?

The filing lists two prior sales of ALHC common stock for JEK TRUST: 298,000 shares sold on August 10, 2026 for $4,136,764.62, and 298,000 shares sold on July 10, 2026 for $5,919,352.80.

What is the origin of the Alignment Healthcare (ALHC) shares being sold?

The filing states that the securities to be sold are Shares Issued Pre-IPO in exchange for Partnership Units, originally issued on May 9, 2014, with the remark that such issuances occurred during the period of May 9, 2014 through March 13, 2025.

Who is the broker for the planned Alignment Healthcare (ALHC) Rule 144 sale?

The proposed sale of 500,000 shares of Alignment Healthcare, Inc. common stock under Rule 144 is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001222028
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALIGNMENT HEALTHCARE INC
SEC File Number	001-40295
Address of Issuer	1100 W. Town and Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	8443102247
Name of Person for Whose Account the Securities are To Be Sold	JEK TRUST U/A DTD 02/08/2021
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	500000	6515000.00	207435149	09/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2014	Shares Issued Pre-IPO in exchange for Partnership Units	Issuer			500000	05/09/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	08/10/2026	298000	4136764.62
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	07/10/2026	298000	5919352.80

144: Remarks and Signature

Remarks	The securities to be sold were Shares Issued Pre-IPO in exchange for Partnership Units during the period of 05/09/2014 through 03/13/2025
Date of Notice	09/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Kao
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)